Mammographic screening: Patterns of use and estimated impact on breast carcinoma survival

被引:74
|
作者
Blanchard, K
Colbert, JA
Puri, D
Weissman, J
Moy, B
Kopans, DB
Kaine, EM
Moore, RH
Halpern, EF
Hughes, KS
Tanabe, KK
Smith, BL
Michaelson, JS
机构
[1] Massachusetts Gen Hosp, Div Surg Oncol, Dept Surg, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[6] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[7] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[8] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
breast carcinoma; mammography; screening; disparity;
D O I
10.1002/cncr.20392
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Although many studies support the life-saving potential of. screening mammography, the actual utilization of screening and the impact of the actual pattern of screening use on the breast carcinoma death rate, remain incompletely understood. In the current report, the authors describe patterns of 2 screening use among women who were examined at a large screening and diagnostic service and estimate the added mortality associated with missed screening mammograms. METHODS. Mammography use was assessed in a population of 72,417 women who received a total of 254,818 screening mammograms at the Massachusetts General Hospital (MGH) Avon Comprehensive Breast Center (Boston, MA) between January 1, 1985, and February 19, 2002. A computer simulation of breast carcinoma growth, spread, and detection of breast carcinoma was used to estimate the likely health consequences of various types of screening use. RESULTS. Both prompt return for annual screening and full use of screening over extended periods of time were rare, and comparison of the MGH population with other populations revealed that the low level of use observed in the MGH population was not atypical. Only 6% of women who received a mammogram in 1992 received all annual mammograms that were available over the next 10 years; the mean number of mammograms received during this period was 5.06, or 51% of the number recommended by the American Cancer Society. Computer simulation results indicate that this underutilization of screening should result in higher mortality levels. Women from traditionally underserved socioeconomic, racial, and ethnic groups, women without insurance, and women who did not speak English had lower levels of use compared with other women. Lower levels of use also were observed among women receiving their first mammogram or who in the past had not returned promptly. Women ages 55-65 years had higher levels of use than did younger or older women. Women who previously had breast carcinoma also had higher levels of screening use. Nonetheless, none of the subpopulations of women stratified by age, race, ethnicity, zip code, income, language, insurance, status, previous screening use, or medical history exhibited a widespread propensity to promptly return for annual screening over an extended period of time. CONCLUSIONS. By many measures, the current analysis is one of the most detailed descriptions of screening use to date. The authors observed a level of screening use that was disappointingly low, with potentially negative health-related consequences, among women across categories defined by racial, ethnic, socioeconomic, and geographic characteristics; insurance status; language; age; medical history; and previous screening use. Improvements in the promptness with which women return to screening appear to have the potential to lead to considerable reductions in breast carcinoma death. (C) 2004 American Cancer Society.
引用
收藏
页码:495 / 507
页数:13
相关论文
共 50 条
  • [41] BREAST-CANCER - MAMMOGRAPHIC SCREENING
    BERAL, V
    [J]. LANCET, 1993, 341 (8859): : 1509 - 1510
  • [42] MAMMOGRAPHIC SCREENING FOR BREAST-CANCER
    RYAN, J
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1979, 1 (01) : 21 - 21
  • [43] Mammographic screening for breast cancer - Reply
    Fletcher, SW
    Elmore, JG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06): : 612 - 612
  • [44] Mammographic Screening for Breast Cancer: 2010
    Margolies, Laurie
    [J]. MOUNT SINAI JOURNAL OF MEDICINE, 2010, 77 (04): : 398 - 404
  • [45] Mammographic screening for breast cancer: A review
    Lee, Warwick
    Peters, Gudrun
    [J]. JOURNAL OF MEDICAL RADIATION SCIENCES, 2013, 60 (01): : 35 - 39
  • [46] MAMMOGRAPHIC PATTERNS OF BENIGN BREAST DISEASES
    FRIEDRICH, M
    [J]. GYNAKOLOGE, 1989, 22 (04): : 230 - 237
  • [47] Age of diagnosis, tumor size, and survival after breast cancer: implications for mammographic screening
    Narod, Steven A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (01) : 259 - 266
  • [48] MAMMOGRAPHIC SCREENING AND MORTALITY FROM BREAST-CANCER - THE MALMO MAMMOGRAPHIC SCREENING TRIAL
    ANDERSSON, I
    ASPERGREN, K
    JANZON, L
    LANDBERG, T
    LINDHOLM, K
    LINELL, F
    LJUNGBERG, O
    RANSTAM, J
    SIGFUSSON, B
    [J]. BRITISH MEDICAL JOURNAL, 1988, 297 (6654): : 943 - 948
  • [49] Mammographic parenchymal, patterns and breast histology
    Bayar, S
    Tükel, S
    Koçak, S
    Aydintug, S
    Sak, SD
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S79 - S79
  • [50] The impact of mammographic screening on breast cancer mortality: overview of the evidence so far
    R Gabe
    SW Duffy
    [J]. Breast Cancer Research, 6 (Suppl 1)